Template:Stent thrombosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(4 intermediate revisions by the same user not shown)
Line 28: Line 28:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
Epidemiology & Demographics
Epidemiology and Demographics
|-  
|-  
!
!
Line 40: Line 40:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
:[[Stent thrombosis incidence in drug eluting stents|Relation to Drug Eluting Stents]]
:[[Stent thrombosis Relation to drug eluting stents|Relation to Drug Eluting Stents]]
|-  
|-  
!
!
Line 46: Line 46:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
:[[Stent thrombosis incidence in drug eluting stents#Sirolimus eluting stent(SES) vs paclitaxel eluting stent(PES)|Sirolimus eluting stent vs Paclitaxel eluting stent]]
:[[Stent thrombosis with antithrombotics|Relation to Antiplatelet Medications]]
|-
!
 
|- bgcolor="Pink"
!
:[[Stent thrombosis with antithrombotics|Relation to antiplatelet medications]]
|-  
|-  
!
!
Line 64: Line 58:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Stent thrombosis risk factors|Risk Factors for Coronary stent thrombosis]]
[[Stent thrombosis risk factors|Risk Factors]]
|-  
|-  
!
!
Line 70: Line 64:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Stent thrombosis relationship to discontinuation of antiplatelet therapy|Premature discontinuation of antiplatelet therapy]]
[[Stent thrombosis relationship to discontinuation of antiplatelet therapy|Relationship to Discontinuation of Antiplatelet Therapy]]
|-  
|-  
!
!
Line 82: Line 76:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Stent thrombosis prognosis|Prognosis]]
[[Stent thrombosis complications|Complications]]
|-  
|-  
!  
!  

Latest revision as of 16:07, 5 March 2013